• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Pediatr . A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey

tetano

Editor, Senior Moderator
Eur J Pediatr


. 2023 May 4.
doi: 10.1007/s00431-023-04982-6. Online ahead of print. A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey

Dilek Yılmaz[SUP] 1 [/SUP], Gülnihan Üstündağ[SUP] 2 [/SUP], Ayşe Büyükçam[SUP] 3 [/SUP], Enes Salı[SUP] 4 [/SUP], Ümit Çelik[SUP] 5 [/SUP], Gülhadiye Avcu[SUP] 6 [/SUP], Nurşen Belet[SUP] 7 [/SUP], Esra Çakmak Taşkın[SUP] 8 [/SUP], Sevliya Öcal Demir[SUP] 9 [/SUP], Ahmet Ziya Birbilen[SUP] 10 [/SUP], Ömer Kılıç[SUP] 11 [/SUP], Özge Metin Akcan[SUP] 12 [/SUP], Ayşe Tekin Yılmaz[SUP] 13 [/SUP], Bilge Aldemir Kocabaş[SUP] 14 [/SUP], Nevin Hatipoğlu[SUP] 15 [/SUP], Adem Karbuz[SUP] 16 [/SUP], Deniz Çakır[SUP] 4 [/SUP], Murat Sütçü[SUP] 17 [/SUP], Fatma Deniz Aygün[SUP] 18 [/SUP], Taylan Çelik[SUP] 19 [/SUP], Semra Bayturan Şen[SUP] 20 [/SUP], Nazan Dalgıç[SUP] 21 [/SUP], Zühal Ümit[SUP] 22 [/SUP], Soner Sertan Kara[SUP] 23 [/SUP], Eda Karadağ Öncel[SUP] 24 [/SUP], Ahmet Bolat[SUP] 25 [/SUP], Merve Kılıç Çil[SUP] 5 [/SUP], Caner Turan[SUP] 26 [/SUP], Ayşe Çakıl Güzin[SUP] 7 [/SUP], Sevgi Topal[SUP] 27 [/SUP], Gülser Esen Besli[SUP] 28 [/SUP], Gizem Doğan[SUP] 29 [/SUP], Sabiha Şahin[SUP] 30 [/SUP], Fatih Akın[SUP] 31 [/SUP], Yaşar Bildirici[SUP] 32 [/SUP], Gülperi Timurtaş Dayar[SUP] 14 [/SUP], Emine Ergül Sarı[SUP] 33 [/SUP], Didem Kızmaz İşançlı[SUP] 16 [/SUP], Manolya Kara[SUP] 17 [/SUP], Pınar Önal[SUP] 18 [/SUP], Hakan Aylaç[SUP] 34 [/SUP], Duygu Lüleci[SUP] 35 [/SUP], Belma Yaşar[SUP] 21 [/SUP], Elif Dede[SUP] 36 [/SUP], Aykut Çağlar[SUP] 37 [/SUP], Sevgi Akova[SUP] 38 [/SUP], Elif Afat Turgut[SUP] 5 [/SUP], Pınar Yazıcı Özkaya[SUP] 39 [/SUP], Tuğba Kandemir Gülmez[SUP] 5 [/SUP], Emel Ulusoy[SUP] 40 [/SUP], Muhterem Duyu[SUP] 41 [/SUP], Yalçın Kara[SUP] 11 [/SUP], Hüseyin Çeliktaş[SUP] 31 [/SUP], Onur Tekeli[SUP] 14 [/SUP], Fatma Çağlar[SUP] 42 [/SUP], Doruk Gül[SUP] 43 [/SUP], Sinem Oral Cebeci[SUP] 44 [/SUP], Fatih Battal[SUP] 34 [/SUP], Alkan Bal[SUP] 45 [/SUP], Emre Aygün[SUP] 46 [/SUP], Metin Uysalol[SUP] 47 [/SUP], Gazi Arslan[SUP] 48 [/SUP], Ayberk Özkavaklı[SUP] 49 [/SUP], Mahmut Can Kızıl[SUP] 11 [/SUP], Abdullah Yazar[SUP] 31 [/SUP], Fatih Aygün[SUP] 50 [/SUP], Ayper Somer[SUP] 36 [/SUP], Necdet Kuyucu[SUP] 51 [/SUP], Ener Çağrı Dinleyici[SUP] 52 [/SUP], Ateş Kara[SUP] 53 [/SUP]



Affiliations
Abstract

This multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID-19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs. What is Known: • Children with COVID-19 mainly present with fever and cough, as in adults. • COVID-19 may specifically threaten children with underlying chronic diseases. What is New: • Children with obesity have a higher vaccination rate against COVID-19 than children without obesity. • Among unvaccinated children, fever and pneumoniae might be seen at a higher ratio than among vaccinated children.

Keywords: COVID-19; Children; Clinical presentation; Multi-center study; Point prevalence study.

 
Back
Top Bottom